
Taking aspirin for a prolonged period could drastically reduce the risk of skin cancer n women, suggests a study recently published in the journal, Cancer.
Dr Jean Tang, of Stanford University School of Medicine in California along with her team followed up the medical history of 59,806 Caucasian women aged between 50 and 79, enrolled in the study, for 12 years.
Advertisement
Researchers took a note of aspirin intake and lifestyle of the women involved in the study. They also took into consideration the factors affecting the risk of melanoma like skin pigmentation, sunscreen usage and exposure to sun.
The analysis revealed that in general, women who take aspirin reduced their risk of skin cancer by 21% and the risk was further reduced by 30% in women who used the painkiller for five or more years.
It is estimated that in 2013 alone in US there could be 9,480 deaths due to melanoma. Hence, the authors opine that with further large scales studies, more lives could be saved from the deadly skin cancer melanoma.
Source: Medindia
It is estimated that in 2013 alone in US there could be 9,480 deaths due to melanoma. Hence, the authors opine that with further large scales studies, more lives could be saved from the deadly skin cancer melanoma.
Source: Medindia
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News

The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.

Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.

The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.

Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.

Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.